Our @JMIRO paper (RANZCR) ranks in the top 10% of most-viewed papers published by the journal in 2024.
HPV-associated oropharyngeal cancer is now the most common mucosal head & neck cancer in Qld. A significant milestone reflecting its relevance & reach. https://t.co/jKA3Lx7Vp2
We’re hiring a hands-on Technical Lead! Love balancing strategy, coding & people leadership? Join us to guide dev teams, shape tech direction & deliver impactful digital outcomes in a fast-paced healthcare environment. 👉 https://t.co/dqkCHCYnXr
New research from CAQ - incidence rates of Merkel cell carcinoma, an aggressive skin cancer, have stabilised after decades of increase. Survival is also improving, especially for advanced cases, likely due to newer treatments like immunotherapy. Read more: https://t.co/dHKbQMmCKG
NEW research on 100k+ #Queenslanders shows rates of second primary invasive #melanomas stabilising after decades of increases - experts credit long-term ☀️sun safety campaigns & better surveillance for the result. Read more: https://t.co/PIA9cUfePP @MelanomaAus@CCQld#SkinCancer
Final day of #MelanomaMarch 🖤 — a reminder that #melanoma continues to impact Queenslanders.
A new statewide #report reveals key trends in melanoma diagnosis, treatment & outcomes across #Queensland. https://t.co/QT5RXlKTZI
Explore local data: https://t.co/D8y3zwtYNC
📣 We’re #Hiring - the #CancerAllianceQld team is growing. We’re recruiting for both a #DataAnalyst and a #ClinicalAnalyst. If your skills and experience meet the criteria of the role, we'd love to hear from you.
Find out more: https://t.co/A7s2aiMJmd
#JoinOurTeam
#OvarianCancerAwareness: the numbers matter! In 2023, 1,965 #Queensland women were diagnosed with ovarian cancer.
💙Every number represents a life and a story.
Understanding the data behind the stories helps improve cancer outcomes.
Explore the data: https://t.co/D8y3zwtYNC
New data alert! Queensland’s 2023 cancer data is now available in the free Cancer Data Explorer. Explore incidence, mortality, survival and more here👉 https://t.co/D8y3zwtYNC
Treatment for early‑stage NSCLC is progressing. Analysis of QOR data (2018–2022) shows stage III patients had much better 5‑year survival when chemoradiotherapy was followed by immunotherapy. New options help tailor care & offer hope for longer survival. https://t.co/riDAJN3HG4
CAQ has released new #research on changes in the epidemiology & management of #OropharyngealCancer in #Qld. The study highlights key areas for improvement, especially treatment & outcome disparities for First Nations peoples and rural areas: https://t.co/sW2sLVTtya #CancerCare
#CervicalCancer is the third most common gynaecological cancer in #Queensland. For the first time, @CAQld has released a statewide 10-year profile (2015–2024) including screening data — showing how #EarlyDetection changes outcomes: https://t.co/9h2ERRyiQP
#QueenslandHealth
Queenslanders face some of the highest #melanoma rates globally. Early detection saves lives — book a professional skin check this #SkinCancerActionWeek.
Read the first population wide report on melanoma in Queensland: https://t.co/QT5RXlKTZI
#MelanomaAwareness#SunSafeQueensland
Join @CAQld and make a real impact on cancer care across the state. As a Clinical Analyst, you’ll leverage your data expertise and leadership to deliver innovative analysis, collaborate with clinicians, and drive meaningful improvements in health outcomes. https://t.co/2jmcFkr5yg
We’re seeking a motivated individual for an exciting part-time Research Officer opportunity — 3 days per week. This is an identified role, which means eligibility criteria applies. If you meet the requirements & your experience aligns, apply today: https://t.co/xrWupQrtr2
Cancer Alliance Queensland release provides the first population wide profile of melanoma diagnoses & treatment in Queensland across the public and private sectors. Read the report: https://t.co/QT5RXlKTZI
#MelanomaAwareness#Queensland#QueenslandHealth#SkinCancer#HealthData